Mary E Aronow, MD

Mary E Aronow, MD

Contact information

Locations
  • Massachusetts Eye and Ear Infirmary
    243, Charles Street, Boston, MA 02114
    617-573-3202
    Map and directions »
Specialty
Ophthalmic Oncologist

Education and Fellowships

Medical school
Yale University School of Medicine
Residency
Cleveland Clinic
Fellowship
Ocular Oncology, Cleveland Clinic
Fellowship
National Eye Institute, National Institutes of Health

Current Positions

Retina and Ocular Oncology Services
Harvard Medical School


Biography

Professional Memberships

International Society of Ocular Oncology
American Academy of Ophthalmology
Association for Research in Vision and Ophthalmology
Faculty of 1000, Associate Faculty (Ophthalmic Oncology Section)
American Medical Association

Board Certification and Licensure

06/2013 - Present, Board Certified, Ophthalmology
04/2013 - Present, Maryland Medical Licensure
08/2010 - 10/2013, Ohio Medical Licensure


Selected publications

  • Ocular adnexal lymphoma: evidence-based treatment approach.
    Aronow ME. Ocular adnexal lymphoma: evidence-based treatment approach. Int Ophthalmol Clin. 2015;55(1):97-109.
  • Intraocular lymphoma models
    Aronow ME, Shen D, Hochman J, Chan CC. Intraocular lymphoma models. Ocular Oncol Pathol. 2015 (in press; accepted 11-26-14)
  • Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
    Minca EC, Tubbs RR, Portier BP, Wang Z, Lanigan C, Aronow ME, Triozzi PL, Singh A, Cook JR, Saunthararajah Y, Plesec TP, Schoenfield L, Cawich V, Sulpizio S, Schultz RA. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication. Cancer Genet. 2014;207(7-8):306-15.
  • Ocular manifestations of hypoxia-inducible factor-2a paraganglioma-somatostatinoma-polycythemia syndrome.
    Pacak K, Chew EY, Pappo AS, Yang C, Lorenzo FR, Wilson MW, Aronow ME, Young JA, Popovic V, Zhuang Z. Ocular manifestations of hypoxia-inducible factor-2a paraganglioma-somatostatinoma-polycythemia syndrome. Ophthalmology. 2014;121(11):2291-3.
  • Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype
    Portell CA, Aronow ME, Rybicki LA, Macklis R, Singh AD, Sweetenham JW. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype. Clin Lymphoma Myeloma Leuk. 2014;14:203-10.
  • Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes.
    Aronow ME, Portell CA, Sweetenham JW, Singh AD. Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes. Ophthalmology 2014;121:334-41.
  • Radiation therapy: conjunctival and eyelid tumors.
    Aronow ME, Singh AD. Radiation therapy: conjunctival and eyelid tumors. Dev Ophthalmol. 2013;52:85-93.
  • Ocular Adnexal Lymphoma: Assessment of a Tumor-Node-Metastasis Staging System.
    Aronow ME, Portell CA, Rybicki LA, Sweetenham JW, Singh AD. Ocular Adnexal Lymphoma: Assessment of a Tumor-Node-Metastasis Staging System. Ophthalmology 2013;120:1915-9.
  • The use of imaging in the diagnosis and management of intraocular lymphoma.
    Aronow ME, Singh AD. The use of imaging in the diagnosis and management of intraocular lymphoma. Int Ophthalmol Clin 2012;52:199-209.
  • Tuberous sclerosis complex:genotype/phenotype correlation of retinal findings
    Aronow ME, Nakagawa J, Gupta A, Traboulsi E, Singh A. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings. Ophthalmology 2012;119:1917-23.
  • The role of biopsy in the assessment of uveal melanoma.
    Aronow ME, Biscotti CV, Chan CC, Singh AD. The role of biopsy in the assessment of uveal melanoma. Retinal Physician 2012;9:13-17.
  • Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature
    Aronow ME, Adamus G, Mones A, Wang Y, Chan C, Singh A. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature. Surv Ophthalmol 2012:57:558-64.
  • Monosomy 3 by FISH in uveal melanoma: variability in techniques and results
    Aronow ME, Sun Y, Saunthararajah Y, Biscotti C, Tubbs R, Triozzi P, Singh A. Monosomy 3 by FISH in uveal melanoma: variability in techniques and results. Surv Ophthalmol 2012;57:463-73.

The Eye Cancer Network is supported by The Eye Cancer Foundation.
Help support eye cancer research and education now »